Avtor/Urednik		Brodowicz, T; Beslija, S; Červek, J; Mršič-Krmpotič, Z; Tchernozemsky, I; Wiltschke, C; Ghilezan, N; Grgič, M; Jassem, J; Zielinski, C
Naslov		Gemcitabine, epirubicin and paclitaxel (GET) vs. 5-fluoro-uracil, epirubicin and cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase iii trial of the Central European cooperative oncology group (CECOG)
Tip		članek
Vir		Eur J Cancer
Vol. in št.		Letnik 37, št. Suppl 6
Leto izdaje		2001
Obseg		str. S194
Jezik		eng